share_log

RBC Capital Initiates Coverage On Applied Therapeutics With Outperform Rating, Announces Price Target of $12

RBC Capital Initiates Coverage On Applied Therapeutics With Outperform Rating, Announces Price Target of $12

加拿大皇家银行资本以跑赢大盘的评级启动对应用疗法的报道,宣布目标股价为12美元
Benzinga ·  03/26 08:53

RBC Capital analyst Brian Abrahams initiates coverage on Applied Therapeutics (NASDAQ:APLT) with a Outperform rating and announces Price Target of $12.

加拿大皇家银行资本分析师布莱恩·亚伯拉罕斯开始对应用疗法(纳斯达克股票代码:APLT)进行报道,评级为跑赢大盘,并宣布目标股价为12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发